Skip to main content

Posts

Showing posts with the label Warren Buffett

Guessing at Value

On August 3, 2011 , Nasdaq.com published an article authored by Louis Navellier, titled “ 5 100 Billion Stocks Not Worth a Dime of Your Money".    Navellier wrote, “ Given that future profits in the stock market are a function of profit growth, owning a $100 billion stock makes little sense .” Navellier's original article Berkshire Hathaway, Inc. (BRK), the conglomerate controlled by Warren Buffett, was Navellier’s top target for dissuading would-be investors.   Among other mistakes, Navellier, without elaboration or substantiation , stated that BRK should be avoided while it was selling at premium prices.   Navellier patently failed to describe his method for determining the intrinsic business value of Berkshire Hathaway; that knowledge would be necessary to wax eloquent as to whether the company was selling at a premium or at a discount.  The ensuing seven years has demonstrated that Navellier was radically wrong . At the time of Navellier's article...

The Great Stock Buyback Conflation

Conflating Shareholders: The stock buyback trend has been extremely hot in the last several years among major U.S. public companies.   Multi-billion-dollar buyback programs are announced by management and the market often reacts positively without any analytical scrutiny.   Buybacks are neither positive nor negative in a vacuum; the efficacy of the program is eventually borne out by whether the shares repurchased were attained well below their intrinsic business value.  If so, accolades to the management; and if not, tomatoes. The bandwagon effect becomes far more dubious among large businesses when management conflates two species of stockholders, those Warren Buffett refers to as Continuing Shareholders and those he calls Departing Shareholders.  This distinction has little relevance most of the time; however, whenever a company announces a stock buyback program, the importance becomes paramount.   The distinction is critical in evaluating the efficacy...